Seeking Alpha

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...
Finanznachrichten

Teva Pharmaceutical Industries Ltd: Teva Announces FDA Approval and Launch of Generic ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva's ...